ENTERPRISE FORUM: “HOW THE HECK ...

ENTERPRISE FORUM: “HOW THE HECK DO YOU COMMERCIALISE BIOMARKERS?”

NISP CONNECT Enterprise Forum Presents:

A Joint Event Production with:

“How the heck do you commercialise biomarkers?”

Perspectives from San Diego, London, and Belfast

Wednesday 12th September, 2012
5pm – 7.45pm
The Northern Ireland Science Park, Innovation Centre

There is a huge pressure on the Pharma and Biotech sector to drastically improve the success rate of bringing drugs through development and approval. At the same time, industry is facing huge pressure due to failing drug pipelines, the unacceptably high cost of development and challenging reimbursement landscape. Superimposed on this “perfect storm” there is acceptance in the industry that many drugs are not effective in a high percentage of the population.

By 2015 the biomarker market is forecast to be worth over $20 Billion with the launch of a number of diagnostic tests to guide the treatment of diseases.

You are invited to listen to the presentation of 6 visions of the opportunities from personalized medicine from perspectives including:

Companion diagnostics

Data & analytics

Investment community

Diagnostics

Clinical study & Design

 

– Register here
– Livestream of the event will be available here: here
– Join the discussion online here.

Event sponsored by:

 

 

 

 

Moderator
Dr Cormac Kilty

Presenters & Panelists 

• Peter Keeling, CEO of Diaceutics
• Prof Richard Kennedy, QUB Almac
• Brian White, Shore Capital
• Roberto Fagnini, Global Business Development, Biotechnology Business Solution (San Diego via webcast)
• Aiden Flynn, Managing Director of Exploristics
• TBC

Click HERE to register

Cost: Free of charge
Date: Wednesday, 12th September 2012
Time: 5pm – 7:45pm Registration & networking
Contact: Meagan Blanton, Northern Ireland Science Park
Tel: 028 9073 7806 Email: Meagan.Blanton@nispconnect.org

Event organizing team
Jennifer Cook, University of Ulster
Peter Donnelly, BioBusiness
Vincent Farrelly, QUB
Tristan Brittain-Dissont, e-synergy
Karl Mulligan, Ex Almac
Steve Orr, NISP CONNECT
Ben Bland, Digital Consultant to NISP
Meagan Blanton, NISP CONNECT

Who should attend?
Founders and executives of science and technology growth companies, business development personnel, researchers, students investors, professional services firms, industry leaders, press and representatives of the region’s economic development agencies. Anyone who cares about transforming Northern Ireland’s economy into one of the hottest in Europe.

About the Speakers

Dr. Cormac Kilty

Dr. Kilty has a Ph.D. in Zoology and Biochemistry from University College Dublin, Ireland. He has carried out post-doctoral research in protein chemistry and immunology at the University of Texas at Austin and at University College Dublin. He joined the Diagnostics Division of Baxter Healthcare in 1986 and from 1987-1991 he was Head of their European Research and Development group in Switzerland. Dr. Kilty was the founder of Biotrin Holdings Ltd which was sold in 2008 to DiaSorin S.p.A. The biomarkers division of Biotrin spun-out to form Argutus Medical, of which Dr. Kilty is now CEO. Dr. Kilty is also a Founder and Chairman of the Irish BioIndustry Association and a member of the Board of NOVA University College Dublin. He is also a Founder of Opsona Therapeutics Ltd.

Aiden Flynn

Aiden Flynn has worked for more than 18 years in the development and application statistics and modelling to drug discovery and development.  After seven years as a Lecturer at University College London, he spent ten years at GlaxoSmithKline as Director of statistical support for biomarker studies across research and development.  Currently, he is Managing Director of Exploristics, the innovative analysis group, with specific interests in study design and optimisation as applied to Personalised Medicine.

 

About NISP CONNECT Enterprise Forum
NISP CONNECT’s Enterprise Forum provides a distinctive perspective on today’s most challenging business issues facing start-ups by producing forums and case study presentations. The Evening Series creates an opportunity for science and technology sector leaders across all industries to connect in a relaxed and inspiring setting.

About BioBusiness
BioBusiness is the business association for the Life and Health Technology sector in Ireland. The core objectives for the association are to:

• Provide and advocacy role for the industry and through leadership represent and lobby for its members to government ministers, government departments and agencies, and regulatory bodies.
• Provide knowledge exchange events for mutual learning, networking and dissemination of best practice.
• Provide business and sector support to enhance the competitiveness of all organisations.
• To create opportunities for business to increase trade and collaborate on research and business opportunities.